News

PipelineReview.com1h
Imdelltra® demonstrated superior overall survival in small cell lung cancer
First Global Phase 3 Trial Showing Substantial Survival Advantage Over Chemotherapy, for Patients With Progression On or After Platinum-Based Chemotherapy ...
Pleural Diseases Market to Expand Significantly by 2032, States DelveInsight Report | Lung Therapeutics, Angiotech Pharmaceuticals, Clover Biopharma
The FDA granted approval for the use of Skytrofa (lonapegsomatropin) in September 2021 for the treatment of pediatric ...